Adamis Pharmaceuticals Corporation announced that it has received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the company that based on the company’s filing of its Quarterly Reports on Form 10-Q for the periods ended March 31, 2021, June 30, 2021 and September 30, 2021.
November 23, 2021
· 1 min read